Summary |
|
|||||||||||||||
Mutation origin |
|
|||||||||||||||
Mutation description |
|
|||||||||||||||
Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
|||||||||||||||
Disease models |
|
|||||||||||||||
Expression |
|
|||||||||||||||
Find Mice (IMSR) |
|
|||||||||||||||
Notes |
Mice homozygous for this allele lack the type 1 receptor (J:14424). Mouse embryos produce TNF and its receptors (J:16646), and the evidence suggests that TNF is involved in important physiological functions. However, homozygous mutant mice develop normally and are fertile with normal litter sizes (J:21202). These mice resist toxicity of low dosage lipopolysaccharide treatment, mediated by the type 1 receptor, although they remain sensitive to high lipopolysaccharide doses. They are also more sensitive to infection with Listeria monocytogenes (J:14424). Cytotoxic T lymphocyte induction by TNF via Tnfrsf1a is not essential to the response to viral infection, homozygous mutant mice being capable of controlling viral infection normally. It is, of course, possible that the essential receptor molecule in these reactions is TNFRSF1B, or that TNFRSF1B can substitute for TNFRSF1A in the absence of the latter (J:21202). A differential response of mutant homozygotes to activation by mouse TNF, which can activate either TNFRSF1A or TNFRSF1B, and human TNF, which is selectively interactive with TNFRSF1A only, suggests that substitution can take place in some circumstances (J:21648). On the other hand, TNF inhibition of Csh2 expression is mediated through the TNFRSF1A, but not the TNFRSF1B, receptor (J:19617).
|
|||||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|